|
May 7
|
Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
|
|
May 2
|
CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
|
|
Apr 16
|
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
|
|
Apr 10
|
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
|
|
Mar 28
|
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 23
|
Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss
|
|
Mar 21
|
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
|
|
Mar 12
|
11 Stocks Insiders are Buying Now
|
|
Feb 5
|
Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?
|
|
Jan 10
|
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
|
|
Dec 20
|
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
|
|
Dec 5
|
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
|
|
Dec 4
|
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
|
|
Dec 3
|
AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT
|
|
Dec 3
|
UPDATE 1-AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT
|
|
Dec 3
|
AstraZeneca ties up with AI biologics company to develop cancer drug
|
|
Aug 10
|
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
|